Loading
Loading…
New
Tenderkart now works inside Claude and ChatGPT: search and analyse tenders right from your chat
Tenderkart now works inside Claude and ChatGPT: search and analyse tenders right from your chat
Loading…
Ref. No.
Eligibility, documents, scope and key termsEligibility, required documents, scope of work and key terms of this tender, in one click.
| # | Company | Offered Item | Amount | Rank | Status |
|---|---|---|---|---|---|
| 1 | L1₹47.9 LQualified Make: Astellas Pharma India Pvt. Ltd.
Model: Gilteritinib 40 mg Tab
Title: Tab Gilteritinib 40 mg | Make: Astellas Pharma India Pvt. Ltd.
Model: Gilteritinib 40 mg Tab
Title: Tab Gilteritinib 40 mg | L1 | Qualified MII |
Tender Value
Refer Docs
EMD Value
₹1.4 L
Closing Date
19 Dec 2024, 5:00 pmClosed
Eligibility, documents, scope and key termsEligibility, required documents, scope of work and key terms of this tender, in one click.
Tab Gilteritinib 40 mg
7198168
GEM/2024/B/5661398
Two Packet Bid
Tab Gilteritinib 40 mg
30 days
Delhi; South West Delhi
Total value wise evaluation
PRODUCT_CUSTOM
8 documents required · 8 mandatory
3 yrs
₹3
80%
| Item | Delivery Location | Qty | Delivery |
|---|---|---|---|
| Tab Gilteritinib 40 mg | SOUTH WEST DELHI | 540 | 30 days |
₹1.4 L
19 Dec 2024
28 Nov 2024
19 Dec 2024
Tap a document below to read it instantly. You can also download everything as a ZIP if you prefer.
bid_7198168.pdf
GEM_BID
bbqr_2024-11-27-13-38-04_a47af0d7602ca5a335a5e6552c4941a4.pdf
SPECIFICATION
ATCDOC_3d337d81-58c0-4cac-88901732790660790_ECHSprocurementbhdc@123.docx
OTHER
list-of-categories-where-trials-are-allowed_1712126171.pdf
OTHER
gtc.pdf
OTHER
Download all tender documents and submit your bid
Disclaimer: TenderKart has made every reasonable effort to ensure that the information on this page is accurate and authentic, however it cannot be held liable for any third-party claims or losses or any damages. TenderKart makes no warranty, expressed or implied, as to the results obtained from the use of this information. If you notice any error or omission, please let us know at .